SCHEDULE: Lytton Holds 9.6% Stake in MDxHealth SA

Laurence W. Lytton has reported a beneficial ownership of 9.6% in MDxHealth SA's ordinary shares.

Summary

• Laurence W. Lytton has filed an amended Schedule 13G, reporting beneficial ownership of 4,943,464 ordinary shares of MDxHealth SA.
• This represents 9.6% of the class of securities outstanding.
• The filing indicates Lytton has sole voting and dispositive power over 3,533,783 shares and shared power over 1,409,681 shares.
• The percentage is calculated based on 51,364,520 ordinary shares outstanding as of December 31, 2025, as per MDxHealth SA's Form 20-F.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, indicating a significant but stable ownership stake without immediate implications for control changes.

Positives

• Laurence W. Lytton maintains a substantial ownership stake of 9.6% in MDxHealth SA, indicating continued investor confidence.
• The filing clearly delineates voting and dispositive power, providing transparency regarding the shareholder's influence.

Negatives

• No specific negative financial or operational information is presented in this ownership filing.

Risks

• Concentration of ownership, while not necessarily negative, can sometimes lead to less diversified shareholder influence.
• The filing does not provide forward-looking statements, so future performance risks are not detailed here.

Future Outlook

This filing is primarily an ownership disclosure and does not contain forward-looking statements or specific future outlook guidance for MDxHealth SA.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual shareholders to report stakes exceeding 5% in publicly traded companies. This filing indicates a substantial, but not controlling, interest in MDxHealth SA.

Stakeholder Impact

• Shareholders: The filing provides transparency on a significant ownership stake, which can influence market perception.
• Management: The filing confirms that the ownership is not intended to influence or change control, as certified by the reporting person.

Next Steps

• Laurence W. Lytton will continue to report any changes in beneficial ownership exceeding the reporting thresholds.
• MDxHealth SA will continue its operations as detailed in its other SEC filings.

Key Dates

Keywords

MDxHealth SA, Schedule 13G, Beneficial Ownership, Ordinary Shares, Laurence W. Lytton, Shareholder, Investment